Skip to the content Skip to the Navigation
GEXVal
  • HOME
  • Our company
    • CEO message
    • Corporate philosophy
    • Origin of the company name
    • Corporate symbol and color
    • Company profile
    • Team
  • Business Model
  • Pipeline
  • To investors
  • News
    • IR
    • Information
    • R&D
  • Contact
  • Language
    • 日本語
    • English
    • 中文 (簡体字)
    • 中文 (繁体字)

News

  1. Top page
  2. News
Information
Lecture by CEO Dr. Kato in “Introduction – Diseases and Drugs” Class in Kyoto Sangyo University
2021/11/30

Read more
Information
Lecture at the 94th Annual Meeting of the Japanese Biochemical Society
2021/10/1

Read more
Information
GEXVal Listed in The Directory of Biotech Startups in Japan 2021-2022 by Nikkei Biotechnology and Business
2021/9/14

Read more
IR
GEXVal Completes JPY 700 Million Series B Financing
2021/9/10

Read more
Information
An article of an interview with the attorney Samejima is published in the journal “THE INDEPENDENTS”
2021/8/27

Read more

Posts pagination

  • «
  • Page 1
  • …
  • Page 11
  • Page 12
  • Page 13
  • …
  • Page 19
  • »

Category

  • Information
  • IR
  • R&D

Copyright © GEXVal All Rights Reserved.

Powered by WordPress with Lightning Theme & VK All in One Expansion Unit

MENU
  • HOME
  • Our company
    • CEO message
    • Corporate philosophy
    • Origin of the company name
    • Corporate symbol and color
    • Company profile
    • Team
  • Business Model
  • Pipeline
  • To investors
  • News
    • IR
    • Information
    • R&D
  • Contact
  • Language
    • 日本語
    • English
    • 中文 (簡体字)
    • 中文 (繁体字)